Ophthalmic Drug Delivery Systems Market Size (By Technology: Eye Drops, Contact Lenses, Punctal Plugs, Episcleral Implants, and Others; By Production Technology: Electrospinning, 3D Printing, Extrusion, Formulation, Micro Patterning, Compression Molding, and Others; By Delivery Route: Intraocular, Intravitreal, and Intracameral; By Material: Liposomes, Collagen, PLA-PEG, PDO/PVA, Hydrogels, TMC, and Others) – Global Industry Analysis, Market Size, Opportunities and Forecast 2022– 2030

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 250

CHAPTER 1. Industry Overview of Ophthalmic Drug Delivery Systems Market

1.1. Definition and Scope

1.1.1. Definition of Ophthalmic Drug Delivery Systems

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Ophthalmic Drug Delivery Systems Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Ophthalmic Drug Delivery Systems Market By Technology

1.2.3. Ophthalmic Drug Delivery Systems Market By Production Technology

1.2.4. Ophthalmic Drug Delivery Systems Market By Delivery Route

1.2.5. Ophthalmic Drug Delivery Systems Market By Material

1.2.6. Ophthalmic Drug Delivery Systems Market By Region


CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources


CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Ophthalmic Drug Delivery Systems Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Ophthalmic Drug Delivery Systems Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material Cost

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2021

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players


CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2021

4.2. R&D Status of Major Manufacturers in 2021


CHAPTER 5. Ophthalmic Drug Delivery Systems Market By Technology

5.1. Introduction

5.2. Ophthalmic Drug Delivery Systems Revenue By Technology

5.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast, By Technology, 2018-2030

5.2.2. Eye Drops

5.2.2.1. Eye Drops Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.3. Contact Lenses

5.2.3.1. Contact Lenses Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.4. Punctal Plugs

5.2.4.1. Punctal Plugs Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.5. Episceral Implants

5.2.5.1. Episceral Drops Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

5.2.6. Others

5.2.6.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030


CHAPTER 6. Ophthalmic Drug Delivery Systems Market By Production Technology

6.1. Introduction

6.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Production Technology

6.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

6.2.2. Electrospinning

6.2.2.1. Electrospinning Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.3. 3D Printing

6.2.3.1. 3D Printing Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.4. Extrusion

6.2.4.1. Extrusion Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.5. Formulation

6.2.5.1. Formulation Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.6. Micro Patterning

6.2.6.1. Micro Patterning Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.7. Compression Molding

6.2.7.1. Compression Molding Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

6.2.8. Others

6.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030


CHAPTER 7. Ophthalmic Drug Delivery Systems Market By Delivery Route

7.1. Introduction

7.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Delivery Route

7.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

7.2.2. Intravitreal

7.2.2.1. Intravitreal Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.3. Intracaramel

7.2.3.1. Intraocaramel Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

7.2.4. Intraocular

7.2.4.1. Intraocular Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030


CHAPTER 8. Ophthalmic Drug Delivery Systems Market By Material

8.1. Introduction

8.2. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) By Material

8.2.1. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

8.2.2. Liposomes

8.2.2.1. Liposomes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.3. Collagen

8.2.3.1. Collagen Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.4. PDO/PVA

8.2.4.1. PDO/PVA Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.5. Hydrogels

8.2.5.1. Liposomes Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.6. PLA-PEG

8.2.6.1. PLA-PEG Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.7. TMC

8.2.7.1. TMC Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030

8.2.8. Others

8.2.8.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2018-2030


CHAPTER 9. North America Ophthalmic Drug Delivery Systems Market By Country 

9.1. North America Ophthalmic Drug Delivery Systems Overview

9.2. U.S.

9.2.1. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

9.2.2. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

9.2.3. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

9.2.4. U.S. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

9.3. Canada

9.3.1. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

9.3.2. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

9.3.3. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

9.3.4. Canada Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

9.4. North America PEST Analysis


CHAPTER 10. Europe Ophthalmic Drug Delivery Systems Market By Country

10.1. Europe Ophthalmic Drug Delivery Systems Overview

10.2. U.K.

10.2.1. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

10.2.2. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

10.2.3. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

10.2.4. U.K. Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

10.3. Germany

10.3.1. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

10.3.2. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

10.3.3. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

10.3.4. Germany Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

10.4. France

10.4.1. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

10.4.2. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

10.4.3. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

10.4.4. France Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

10.5. Spain

10.5.1. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

10.5.2. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

10.5.3. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

10.5.4. Spain Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

10.6. Rest of Europe

10.6.1. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

10.6.2. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

10.6.3. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

10.6.4. Rest of Europe Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

10.7. Europe PEST Analysis


CHAPTER 11. Asia Pacific Ophthalmic Drug Delivery Systems Market By Country

11.1. Asia Pacific Ophthalmic Drug Delivery Systems Overview

11.2. China

11.2.1. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.2.2. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.2.3. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.2.4. China Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.3. Japan

11.3.1. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.3.2. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.3.3. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.3.4. Japan Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.4. India

11.4.1. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.4.2. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.4.3. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.4.4. India Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.5. Australia

11.5.1. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.5.2. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.5.3. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.5.4. Australia Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.6. South Korea

11.6.1. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.6.2. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.6.3. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.6.4. South Korea Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.7. Rest of Asia-Pacific

11.7.1. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

11.7.2. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

11.7.3. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

11.7.4. Rest of Asia-Pacific Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

11.8. Asia Pacific PEST Analysis


CHAPTER 12. Latin America Ophthalmic Drug Delivery Systems Market By Country

12.1. Latin America Ophthalmic Drug Delivery Systems Overview

12.2. Brazil

12.2.1. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

12.2.2. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

12.2.3. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

12.2.4. Brazil Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

12.3. Mexico

12.3.1. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

12.3.2. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

12.3.3. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

12.3.4. Mexico Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

12.4. Rest of Latin America

12.4.1. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

12.4.2. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

12.4.3. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

12.4.4. Rest of Latin America Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

12.5. Latin America PEST Analysis


CHAPTER 13. Middle East & Africa Ophthalmic Drug Delivery Systems Market By Country 

13.1. Middle East & Africa Ophthalmic Drug Delivery Systems Overview

13.2. GCC

13.2.1. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

13.2.2. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

13.2.3. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

13.2.4. GCC Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

13.3. South Africa

13.3.1. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

13.3.2. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

13.3.3. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

13.3.4. South Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

13.4. Rest of Middle East & Africa

13.4.1. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Technology, 2018-2030

13.4.2. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Production Technology, 2018-2030

13.4.3. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Delivery Route, 2018-2030

13.4.4. Rest of Middle East & Africa Ophthalmic Drug Delivery Systems Revenue (US$ Mn) and Forecast By Material, 2018-2030

13.5. Middle East & Africa PEST Analysis


CHAPTER 14. Player Analysis Of Ophthalmic Drug Delivery Systems Market

14.1. Ophthalmic Drug Delivery Systems Market Company Share Analysis

14.2. Competition Matrix

14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

14.2.2. New Technology Launches and Technology Enhancements

14.2.3. Mergers And Acquisition In Global Ophthalmic Drug Delivery Systems market

14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements


CHAPTER 15. Company Profile

15.1. Allergan plc

15.1.1. Company Snapshot

15.1.2. Business Overview

15.1.3. Financial Overview

15.1.3.1. Revenue (US$ Mn), 2021

15.1.3.2. Allergan plc2021 Ophthalmic Drug Delivery Systems Business Regional Distribution

15.1.4. Product/Service and Specification

15.1.5. Recent Developments & Business Strategy

15.1.6. Manufacturing Plant Footprint Analysis

15.2. AptarGroup, Inc.

15.3. Clearside Biomedical

15.4. Envisia Therapeutics

15.5. Ocular Therapeutix Inc.

15.6. Oculis Pharma

15.7. pSivida

15.8. Santen Pharmaceutical Co. Ltd.

15.9. Valeant Pharmaceuticals

Cart Summary